Description
DROXIDOPA 300MG
First action · last action
2015-07-16 · 2016-02-05
Transactions
2
First transaction's obligation
$18,986
Base + all options value (sum of deltas)
$12,658
Extent competed
NOT COMPETED
Other than full & open authority
URGENCY
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
446110 · PHARMACIES AND DRUG STORES
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-07-16+$18,986= $18,986
- Mod P000012016-02-05-$6,329= $12,658
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-07-16 | +$18,986 | $18,986 | DROXIDOPA 300MG |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2016-02-05 | −$6,329 | $12,658 | DROXIDOPA 300MG |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI EP32BZ8XN3A2)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26123P0628 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $14,221 | FY2023 |
| 36C26123P0590 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2023 |
| 36C26123P0479 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $13,557 | FY2023 |
| 36C26123P0366 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $13,557 | FY2023 |
| 36C26123P0086 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $13,557 | FY2023 |
| 36C26122P1803 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $13,557 | FY2022 |
Other recipients under 6505 from 656-ST CLOUD VA MEDICAL CENTER (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA26316J0448 | SANOFI VACCINES US INC. | 656-ST CLOUD VA MEDICAL CENTER | $235,747 | FY2016 |
| VA26316J0423 | EXELIXIS, INC. | 656-ST CLOUD VA MEDICAL CENTER | $20,624 | FY2016 |
| VA26316J0398 | SEQIRUS USA INC | 656-ST CLOUD VA MEDICAL CENTER | $103,664 | FY2016 |
| VA26316J0400 | SEQIRUS USA INC | 656-ST CLOUD VA MEDICAL CENTER | $33,463 | FY2016 |
| VA26316J0416 | SEQIRUS USA INC | 656-ST CLOUD VA MEDICAL CENTER | $12,140 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26315P0765_3600_-NONE-_-NONE- · retrieved 2026-09-26.